IMC Chicago’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,131
Closed -$808K 6452
2026
Q1
$762K Sell
12,131
-9,957
-45% -$693K ﹤0.01% 3558
2025
Q4
$1.47M Buy
22,088
+10,754
+95% +$695K ﹤0.01% 2670
2025
Q3
$763K Buy
+11,334
New +$897K ﹤0.01% 2900
2024
Q4
Sell
-54,922
Closed -$4.07M 3193
2024
Q3
$3.68M Buy
+54,922
New +$4.51M ﹤0.01% 1297
2023
Q4
Sell
-14,496
Closed -$1.48M 1841
2023
Q3
$1.35M Buy
+14,496
New +$1.63M ﹤0.01% 1120

Other funds holding DXCM

IMC Chicago's DXCM Position: Q2 2026 in Review

IMC Chicago sold out of DexCom (DXCM) in Q2 2026, closing a stake of 12,131 shares — an estimated $808K sold.

IMC Chicago first reported a position in DXCM in Q3 2023 and held it in 5 quarters. The position peaked at $3.68M in Q3 2024. 585 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • IMC Chicago reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 12,131 DexCom shares in Q2 2026, an estimated $808K.
  • IMC Chicago first reported a position in DexCom in Q3 2023 and held it in 5 quarters.
  • IMC Chicago's DexCom position peaked at $3.68M in Q3 2024.
  • 585 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.